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The intercellular adhesion molecule-1 (ICAM-1) expression is frequently correlated
with the lung inflammation. In lung injury, sphingosine-1-phosphate (S1P, bioactive
sphingolipid metabolite), participate gene regulation of adhesion molecule in
inflammation progression and aggravate tissue damage. To investigate the transduction
mechanisms of the S1P in pulmonary epithelium, we demonstrated that exposure of
HPAEpiCs (human pulmonary alveolar epithelial cells) to S1P significantly induces ICAM-
1 expression leading to increase monocyte adhesion on the surface of HPAEpiCs.
These phenomena were effectively attenuated by pretreatments with series of inhibitors
such as Rottlerin (PKCδ), PF431396 (PYK2), diphenyleneiodonium chloride (DPI),
apocynin (NADPH oxidase), Edaravone (ROS), and Bay11-7082 (NF-κB). Consistently,
knockdown with siRNA transfection of PKCδ, PYK2, p47phox, and p65 exhibited the
same results. Pretreatment with both Gq-coupled receptor antagonist (GPA2A) and
Gi/o-coupled receptor antagonist (GPA2) also blocked the upregulation of ICAM-1
protein and mRNA induced by S1P. We observed that S1P induced PYK2 activation via
a Gq-coupled receptor/PKCδ-dependent pathway. In addition, S1P induced NADPH
oxidase activation and intracellular ROS generation, which were also reduced by
Rottlerin or PF431396. We demonstrated that S1P induced NF-κB p65 phosphorylation
and nuclear translocation in HPAEpiCs. Activated NF-κB was blocked by Rottlerin,
PF431396, APO, DPI, or Edaravone. Besides, the results of monocyte adhesion
assay indicated that S1P-induced ICAM-1 expression on HPAEpiCs can enhance the
monocyte attachments. In the S1P-treated mice, we found that the levels of ICAM-1
protein and mRNA in the lung fractions, the pulmonary hematoma and leukocyte
count in bronchoalveolar lavage fluid were enhanced through a PKCδ/PYK2/NADPH
oxidase/ROS/NF-κB signaling pathway. We concluded that S1P-accelerated lung
damage is due to the ICAM-1 induction associated with leukocyte recruitment.
Keywords: sphingosine-1-phosphate, intercellular adhesion molecule-1, lung inflammation, transcription factor,
monocyte adhesion
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INTRODUCTION
Sustained stimulation and inflammation in respiratory system
are pivotal events in pathogenic progressing of asthma or
other chronic obstructive pulmonary diseases. To regulate
inflammatory responses, not only initiated complicated
interaction of the intracellular molecules but also recruited
serious intercellular interactions such as lung resident cells,
vascular endothelium and circulating polymorphonuclear
cells (PMNs) (Lin et al., 2015). Previous studies indicate that
pro-inflammatory cytokine-induced expression of adhesion
molecules on the endothelial cells surface is implicated in the
inflammatory responses and facilitate (or guidance) PMNs
infiltration to the inflammatory area. (Kim et al., 2008; Lee and
Yang, 2012). In the classification of adhesion molecules, these
molecules were divided into two groups: the Ig superfamily
and selectins. ICAM-1 and VCAM-1 are belong to the Ig
superfamily (Lee and Yang, 2013). The inducible endothelial
adhesive glycoprotein, ICAM-1, is identified on several types
of cells (Albelda et al., 1994; Rahman and Fazal, 2009). In the
regulation of transendothelial migration, ICAM-1 expression can
mediate the tight adhesiveness of PMNs. PMNs were arrested at
non-junctional locations to penetrate the vascular endothelium
barrier and then attached on the resident cells (Yang et al., 2005;
Lee et al., 2013b).
Sphingosine 1-phosphate (S1P, a bioactive sphingolipid
metabolite) plays important roles in allergic responses, including
asthma, and anaphylaxis (Ammit et al., 2001). S1P regulates
numerous cellular responses, including motility, and cytoskeletal
rearrangements, formation of adherent junctions, proliferation,
survival, angiogenesis, and the trafficking of several types of
cells (Ryan and Spiegel, 2008; Li et al., 2009). These myriad
effects are partly elicited by binding of S1P to a family of
five G protein–coupled receptors (S1PRs), termed S1PR1–5.
Moreover, S1P has been shown to induce lung injury and
inflammation (Sun et al., 2013). In addition, S1P has been
also shown to induce ICAM-1 or VCAM-1 expression in
various cell types (Milara et al., 2009; Costello et al., 2011).
However, the mechanisms of S1P-regulated ICAM-1 expression
in human pulmonary alveolar epithelial cells (HPAEpiCs) are
not completely understood. Thus, to clarify the mechanisms of
ICAM-1 induction by S1P on pulmonary alveolar epithelium
was proposed to be a new therapeutic target in the respiratory
diseases.
PKCδ was first identified from mammalian cDNA libraries
and classified to be a member of novel PKC subfamily. Different
to the other tissue- specific PKC members, PKCδ is one of
the widespread PKC isoform among several cells and tissues
(Aris et al., 1993; Rahman et al., 2001; Kikkawa et al., 2002).
Various reports indicate that activity of PKCδ is a critical player
in cellular function to regulate cell fates, such as cell cycle,
apoptosis or differentiation (Kikkawa et al., 2002; Vallee et al.,
2004). Several reports indicate that PKCδ participates in the signal
transduction of PYK2 (proline-rich tyrosine kinase 2) in response
to the outside stimulation (Frank et al., 2002; Farshori et al.,
2003). In addition, a phorbol ester activator of PKC, phorbol
myristate acetate (PMA) has been demonstrated to stimulate
the phosphorylations of PKCδ and PYK2 in pancreatic acinar
cells (Wrenn, 2001). Both of the PYK2 and FAK (focal adhesion
tyrosine kinases) have been shown to be the key signaling
components to regulate cellular behaviors including migration,
proliferation, and survival (Lipinski and Loftus, 2010; Lee and
Yang, 2013). Several reports indicate that both of PKCδ (Woo
et al., 2005; Yang S.F. et al., 2010; Mondrinos et al., 2014;
Lee et al., 2015) and PYK2 (Zhao et al., 2014) affect ICAM-1
expression (Vallee et al., 2004). We suggested that PKCδ and
PYK2 may be required for the S1P-induced VCAM-1 expression
in HPAEpiCs.
In pulmonary inflammatory diseases, the accumulation
of chronic inflammatory factors and imbalance between
oxidant/antioxidant promote seriously cellular damages
including the respiratory tissue injury. The ROS (reactive
oxygen species) are considered to be the important mediators
to affect cellular behaviors such as cell migration, adhesion,
growth, differentiation, senescence, and apoptosis. The excessive
amount of ROS generation was associated with respiratory
inflammatory diseases (Lee and Yang, 2012). TNF-α, one
of the pro-inflammatory mediators, activates the NADPH
oxidase and leading to ROS overproduction which mediates
the ICAM-1 and VCAM-1 inductions (Lee and Yang, 2012,
2013). Previous reports indicate that several responsible elements
for transcription factors are identified to regulate ICAM-1
promoter, including NF-κB (Roebuck and Finnegan, 1999;
Yang C.M. et al., 2010; Hadad et al., 2011). In inflammatory
reactions, IKK-dependent IκB degradation is initiated to
activate NF-κB. The released NF-κB subunit is translocated
into nuclei and regulated the gene expressions (Baeuerle and
Baltimore, 1996; Shih et al., 2015). Besides the typical regulated
pathway, our findings indicated that NF-κB activity is also
activated by another multiple mechanisms, such as PKCδ
(Lin et al., 2014), PYK2 (Lee and Yang, 2013), and NADPH
oxidase/ROS (Lee and Yang, 2013). These results demonstrate
that various signaling molecules are involved in the regulation
of ICAM-1 induction. However, the signal transductions
participated in NF-κB-dependent ICAM-1 expression and
monocyte adhesion on S1P-challenged HPAEpiCs remain
unknown.
In addressing these questions, experiments were undertaken
to investigate the effects of S1P on expression of ICAM-1 and
monocyte adhesion on HPAEpiCs. These findings suggest that
the increased expression of ICAM-1 and monocyte adhesion on
S1P-challenged HPAEpiCs are mediated through Gq- and Gi/o-
coupled receptor/PKCδ/PYK2/NADPH oxidase/ROS-dependent
NF-κB activation. These findings proposed new insights of
the mechanisms of S1P stimulation to regulate the expression




DMEM/F-12 medium, fetal bovine serum (FBS), TRIzol reagent
and PLUS-Lipofectamine were from Invitrogen (Carsbad, CA,
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USA). Hybond C membrane and enhanced chemiluminescence
(ECL) detection system were from GE Healthcare Biosciences
(Buckinghamshire, UK). Anti-ICAM-1, anti-GAPDH, anti-
PKCδ, anti-PYK2, anti-p47phox, and anti-p65 antibodies were
from Santa Cruz (Santa Cruz, CA, USA). Anti-phospho-PKCδ,
anti-phospho-PYK2, and anti-phospho-p65 antibodies were
from Cell Signaling (Danvers, MA, USA). Actinomycin D
(Act. D), cycloheximide (CHI), GP antagonist-2 (GPA2),
GP antagonist-2A (GPA2A), Rottlerin, PF431396, Bay11-
7082, Edaravone, diphenyleneiodonium chloride (DPI), and
apocynin (APO) were from Biomol (Plymouth Meetings,
PA, USA). S1P was from Cayman (Ann Arbor, MI, USA).
Luciferase assay kit was from Promega (Madison, WI,
USA). SDS-PAGE reagents were from MDBio Inc (Taipei,
Taiwan). 2′,7′-dichlorodihydrofluorescein diacetate (DCFH-DA)
and 2′,7′-Bis-(2-carboxyethyl)-5-(and-6)-carboxyfluorescein,
acetoxymethyl ester (BCECF/AM) were from Molecular Probes
(Eugene, OR, USA). All other reagents were from Sigma (St.
Louis, MO, USA).
Cell Culture and Treatment
Human pulmonary alveolar epithelial cells (HPAEpiCs) were
purchased from the ScienCell Research Laboratories (San
Diego, CA, USA) and grown as previously described (Lee
et al., 2013a). Experiments were performed with cells from
passages 4 to 8. Treatment of HPAEpiCs with DMSO or
the pharmacological inhibitors alone had no significant effect
on cell viability determined by a 2,3-bis-(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT) assay (data
not shown).
Transient Transfection with siRNAs
Human siRNAs of PKCδ (SASI_Hs01_00061170), PYK2
(SASI_Hs01_00032249), p47phox (SASI_Hs02_00302212), p65
(SASI_Hs01_00171091), or scrambled control (St. Louis, MO,
USA) were used to knockdown the specific gene expression. The
transient transfection of siRNA (100 nM) was performed with
Metafectene transfection reagent according to the manufacturer’s
protocol (Biontex, Germany).
Preparation of Cell Extracts and Western
Blot Analysis
Quiescent cells were treated with S1P for the indicated time
intervals. The cells were harvested as previously described
(Lee et al., 2013a). Samples were analyzed by using 10%
SDS-PAGE and transferred to nitrocellulose membrane.
Membranes were probed with an anti-ICAM-1 antibody
(1:1000) and then membranes were incubated with horseradish
peroxidase conjugated anti-rabbit antibody (1:2000) for 1 h
at room temperature. The membranes were washed with
tween-Tris buffered saline and detected by ECL reagents. The
immunoblotting signals were captured by UVP BioSpectrum
500 Imaging System (Upland, CA, USA). The UN-SCAN-IT
gel software (Orem, UT, USA) was used to quantify image
densitometry.
Total RNA Extraction and Real-time PCR
Analysis
Total RNA were extracted with TRIzol reagent (Thermo
Fisher, Waltham, MA, USA) according to the protocol of
the manufacturer. The cDNA obtained from 5 µg total RNA
was used to be a template for PCR amplification (Torre-
Amione et al., 1996). Real-time PCR was performed with
KAPA PROBE FAST ABI Prism
R©
qPCR kit (KK4705, Kapa
Biosystems, Wilmington, MA, USA) and 7500 Real-Time PCR
System (Applied Biosystems, Foster City, CA, USA) to analyze
the amounts of ICAM-1 and GAPDH mRNA. Fold-changes of
gene expression were calculated with the 11Ct method and all
analysis were performed in triplicate (n= 3).
Cell Adhesion Assay
Confluent HPAEpiCs on 6-well plates were treated with S1P for
16 h, and then adhesion assays were performed as previously
described (Lin et al., 2016). Briefly, THP-1 cells (human acute
monocytic leukemia cell line) were incubated with 10 µM
BCECF/AM in RPMI-1640 medium (Gibco BRL, Grand Island,
NY, USA) at 37◦C for 1 h. HPAEpiCs were incubated with
these labeled THP-1 cells (2 × 106 cells/ml) for 1 h. The non-
adherent THP-1 cells were removed by gently PBS-wash twice.
The attached THP-1 cells were observed and measured with a
fluorescence microscope (Zeiss, Axiovert 200 M). Experiments
were performed in triplicate and repeated at least three
times.
Plasmid Construction, Transfection, and
Luciferase Reporter Gene Assays
The human ICAM-1 (pIC-339) firefly luciferase was kindly
provided by Dr. P. T. van der Saag (Hubrecht Laboratory,
Utrecht, The Netherlands). All plasmids were prepared by
using QIAGEN plasmid DNA preparation kits. ICAM-1-luc
activity was determined using a luciferase assay system (Promega,
Madison, WI, USA) as previously described (Lee et al.,
2013b).
Determination of NADPH Oxidase
Activity by Chemiluminescence Assay
The Nox activity was examined by lucigenin chemiluminescence
assay according to the previous report (Hsieh et al., 2012) with
minor modification. After incubation, the collected cell pellet
was resuspended with 35 µl of ice-cold RPMI-1640 medium
on ice bath. To initiate the enzyme reaction, 5 µl of cell
suspension (0.2 × 105 cells) was added to 200 µl of pre-warmed
(37◦C) RPMI-1640 medium containing either NADPH (1 µM)
or lucigenin (20 µM) and then the chemiluminescence was
immediately measured by an Appliskan luminometer (Thermo
R©
)
in out-of-coincidence mode. Appropriate blanks and controls
were established. Neither NADPH nor NADH enhanced the
background chemiluminescence of lucigenin alone (30–40 counts
per min). Chemiluminescence was continuously measured for
12 min, and the activity of NADPH oxidase was expressed as
counts per million cells.
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Measurement of Intracellular ROS
Generation
The measurement of generation of intracellular ROS was
performed with peroxide-sensitive fluorescent probe (2′,7′-
dichlorofluorescein diacetate, DCF-DA) as previous described
(Lin et al., 2016). Washed HPAEpiCs were labeled with 10 µM
DCFH-DA in HBSS for 30 min. Subsequently, the free DCFH-DA
was removed and replaced with fresh medium. HPAEpiCs were
treated with various concentrations of S1P. Cells were detached
with trypsin/EDTA, and the fluorescence intensity of the cells was
analyzed with FACScan flow cytometer (BD Biosciences, San Jose,
CA, USA) at 495 nm excitation and 529 nm emission for DCF.
Immunofluorescence Staining
Sphingosine-1-phosphate-treated HPAEpiCs for the indicated
time intervals were washed twice with ice-cold PBS and fixed
with 4% paraformaldehyde. The fixed cells were permeabilized,
and probed with the primary antibody, anti-p65 antibody,
as previously described (Lee et al., 2013b). The images were
observed and captured with fluorescence microscope (Zeiss,
Axiovert 200 M).
Chromatin Immunoprecipitation Assay
The chromatin immunoprecipitation (ChIP) analysis was
performed to analysis the transcription factor association on
human ICAM-1 promoter in vivo as previously described
(Lee et al., 2007). Briefly, HPAEpiCs were cross-linked with
1% formaldehyde at 37◦C for 10 min and stop this reaction
with 0.125 M glycin. ChIP assay kit (Upstate) was used to
prepare the soluble chromatin/protein complex according to
the manufacturer’s protocol and immunoprecipitated with anti-
p65 antibody or normal IgG. Following washes and elution,
immunoprecipitated complex was heated overnight at 65◦C to
remove cross-linking of DNA and protein. DNA fragments
were purified by phenol-chloroform extraction and ethanol
precipitation. PCR fragments were analyzed on 2% agarose in 1X
TAE gel containing ethidium bromide.
Animal Care and Experimental
Procedures
Male ICR mice aged 6–8 weeks were purchased from the
National Laboratory Animal Centre (Taipei, Taiwan) and handled
according to the guidelines of Animal Care Committee of Chang
Gung University and NIH Guides for the Care and Use of
Laboratory Animals. ICR mice were anesthetized with Zoletil
(40 mg/kg) and placed individually on a board in a near vertical
position and the tongues were withdrawn with a lined forceps.
S1P (3 mg/kg body weight, 50 µl of 5 mM S1P, about 30 g
of body weight/mouse) was placed posterior in the throat and
aspirated into lungs. DMSO- administrated mice were used to
be the control group. After 15 min, regained consciousness
mice were i.p. given one dose of GPA2A, Rottlerin, PF431396,
DPI, APO, Edaravone, or Bay11-7082 (2 mg/kg) for 2 h prior
to S1P treatment, and sacrificed after 24 h. To examine the
levels of ICAM-1 mRNA and protein expression, lung tissues
were collected, homogenized and subjected to real-time PCR and
Western blot, as previously described (Lee et al., 2007).
Isolation of Bronchoalveolar Lavage
(BAL) Fluid
Mice were injected with 3 mg/kg S1P for 24 h and then killed
to harvest BAL fluid. BAL fluid was obtained through tracheal
cannula using aliquots of 1 ml ice–cold PBS, as previously
described (Lee et al., 2007). BAL fluid was collected and
centrifuged at 500 × g at 4◦C, and cell pellets were washed and
re-suspended in PBS. The number of leukocyte was measured
with hemocytometer.
Statistical Analysis of Data
All the data were expressed as the mean or mean ± SEM of
three individual experiments performed in duplicate or triplicate,
as previously described (Lin et al., 2016). The significance of
difference between two groups was determined by paired two-
tailed Student’s t-test for western blot data. All others statistical
analyses are comparison of multiple groups, a GraphPad
Prism Program (GraphPad, San Diego, CA, USA) by one-
way analysis of variance (ANOVA) followed with Tukey’s post
hoc test has been used. A P < 0.05 value was considered
significant.
RESULTS
S1P-Induced ICAM-1 Expression in
Transcription and Translation
Our previous report indicated that the concentration of S1P
(10 µM) used to obtain a maximal ICAM-1 expression which
was applied in this study (Lin et al., 2015). To examine the
mechanisms of S1P-induced ICAM-1 expression, HPAEpiCs
were stimulated with S1P (10 µM) in the pretreatment with
(or without) (Act. D, transcriptional inhibitor) or cycloheximide
(CHI, translational inhibitor) and then Western blotting was
performed to analyze ICAM-1 protein expression. Our data
indicated that both of Act. D and CHI treatments can attenuate
the S1P-mediated ICAM-1 induction in a dose-dependent
manner (Figure 1A). Besides, Act. D, but not CHI, significantly
reduced S1P-induced ICAM-1 mRNA expression in HPAEpiCs
(Figure 1B). Next, we found that adhesion of THP-1 to
HPAEpiCs was enhanced by S1P challenge about fivefold, which
was also obviously inhibited by pretreatment with Act. D or
CHI (Figure 1C). Taken together, we suggested that S1P-induced
ICAM-1 expression depends on de novo protein synthesis in
HPAEpiCs.
Gq- and Gi/o-Coupled Receptors Play
Key Roles in S1P-Induced ICAM-1
Expression
Sphingosine-1-phosphate regulates numerous cellular responses,
including formation of adherent junctions, proliferation,
migration, and survival (Ryan and Spiegel, 2008; Takashima
et al., 2008; Li et al., 2009). These myriad effects are partly elicited
Frontiers in Pharmacology | www.frontiersin.org 4 March 2016 | Volume 7 | Article 80
fphar-07-00080 March 30, 2016 Time: 19:56 # 5
Lin et al. S1P Induces ICAM-1 Expression
FIGURE 1 | Sphingosine-1-phosphate-induced ICAM-1 expression requires ongoing transcription and translation. (A) Cells were pretreated with
Actinomycin D (Act. D) or CHI for 1 h, and then incubated with 10 µM S1P for 16 h. The ICAM-1 protein expression was determined by Western blot. (B) Cells were
pretreated with Act. D (10 nM) or CHI (1 µM) for 1 h, and then incubated with 10 µM S1P for 4 h. The ICAM-1 mRNA expression was determined by real-time PCR.
(C) Cells were pretreated with Act. D (10 nM) or CHI (1 µM) for 1 h, and then incubated with 10 µM S1P for 16 h. The THP-1 cells adherence was measured. Data
are expressed as mean ± SEM of three independent experiments. ∗P < 0.05; #P < 0.01, as compared with the cells exposed to S1P alone.
by binding of S1P to a family of five G protein–coupled receptors,
termed S1PR1–5. S1PR1, S1PR2, and S1PR3 are ubiquitously
expressed, whereas the levels of S1PR4 and S1PR5 expression
are predominantly existed in immune cells, CNS, and some
organs. Indeed, S1PR1, 2 and 3 are expressed on HPAEpiCs
(Lin et al., 2015). Thus, we further investigated whether Gq- or
Gi/o-coupled receptor was involved in S1P-induced ICAM-1
expression. As shown in Figures 2A,B, our data indicated that
pretreatments of GPA2A (Gq-coupled receptor antagonist)
and GPA2 (Gi/o-coupled receptor antagonist) concentration-
dependently block the S1P-induced ICAM-1 expression in
protein (∼63%) and mRNA (∼68%), respectively. The analysis
of promoter activity (∼62%) also exhibit consistent results.
Finally, we observed that S1P-enhanced monocyte adhesion
was also reduced to approximate 70% of control by these two
inhibitors (Figure 2C). Taken together, we suggested that Gq-
and Gi/o-coupled receptors play key roles in S1P-induced
ICAM-1 expression in HPAEpiCs.
PKCδ is Involved in S1P-Induced ICAM-1
Expression
Several lines of evidence indicate that PKCδ activity plays critical
roles to regulate cellular physiological functions (Kikkawa et al.,
2002). We also obtained the similar results that pretreatment
of Rottlerin (selective PKCδ inhibitor) significantly attenuate
S1P-induced ICAM-1 protein expression by approximate 85%
(Figure 3A). This inhibitory phenomenon was also exhibited in
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FIGURE 2 | Gq-coupled receptor and Gi/o-coupled receptor play key roles in S1P-induced ICAM-1 expression. (A) Cells were pretreated with GPA2 or
GPA2A for 1 h, and then incubated with 10 µM S1P for 16 h. The ICAM-1 protein expression was determined by Western blot. (B) Cells were pretreated with GPA2
(1 µM) or GPA2A (1 µM) for 1 h, and then incubated with 10 µM S1P for 4 h. The ICAM-1 mRNA expression and promoter activity were determined by real-time
PCR and promoter assay, respectively. (C) Cells were pretreated with GPA2 (1 µM) or GPA2A (1 µM) for 1 h, and then incubated with 10 µM S1P for 16 h. The
THP-1 cells adherence was measured. Data are expressed as mean ± SEM of three independent experiments. #P < 0.01, as compared with the cells exposed to
S1P alone.
mRNA by approximate 95% (Figure 3B) and promoter activity by
approximate 55% (Figure 3B). To confirm that PKCδ is involved
in S1P-induced ICAM-1 expression, siRNA transfection was used
to knockdown PKCδ expression. The results of Western blotting
indicated that PKCδ siRNA transfection reduces PKCδ protein
by approximate 55%, and then inhibits the S1P-induced ICAM-
1 expression by approximate 40% (Figure 3C). Consistently,
pretreatment with Rottlerin also decreased monocyte adhesion to
the cell surface of HPAEpiCs challenged with S1P by approximate
65% (Figure 3D). Especially, we found that S1P can trigger
PKCδ phosphorylation with a time-dependent manner, which
was reduced by pretreatment of Rottlerin and GPA2A, but not
GPA2 (Figure 3E). Taken together, we demonstrated that the
Gq-coupled receptor/PKCδ activation mediate S1P stimulated
ICAM-1 expression in these cells.
PYK2 is a Key Point in Regulating
S1P-Induced ICAM-1 Expression
Exposure of PMA has been shown to stimulate the
phosphorylation of PKCδ and PYK2 in pancreas acinar
cells (Wrenn, 2001). Based on this finding, we focused to
study the role of PYK2 in S1P-induced ICAM-1 expression.
The results of Western blotting indicated that pretreatment
of PF431396 (an inhibitor of PYK2) reduced S1P-induced
ICAM-1 protein expression by approximate 91% (Figure 4A).
The mRNA level and promoter activity of ICAM-1 also
exhibited consistent inhibitory results by approximate
89 and 55%, respectively (Figure 4B). To investigate the
regulatory role of PYK2 in the pathway of S1P-induced
ICAM-1 expression, PYK2 siRNA was used to block the PYK2
expression. As expected, PYK2 siRNA transfection reduced
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FIGURE 3 | PKCδ is involved in S1P-induced ICAM-1 expression. (A) Cells were pretreated with Rottlerin for 1 h, and then incubated with 10 µM S1P for 16 h.
The ICAM-1 protein expression was determined by Western blot. (B) Cells were pretreated with Rottlerin (10 µM) for 1 h, and then incubated with 10 µM S1P for
4 h. The ICAM-1 mRNA expression and promoter activity were determined by real-time PCR and promoter assay, respectively. (C) Cells were transfected with siRNA
of scrambled or PKCδ, and then incubated with 10 µM S1P for 16 h. The levels of PKCδ and ICAM-1 proteins were determined by Western blot. (D) Cells were
pretreated with Rottlerin (10 µM) for 1 h, and then incubated with 10 µM S1P for 16 h. The THP-1 cells adherence was measured. (E) Cells were pretreated without
or with Rottlerin, GPA2A, or GPA2 for 1 h, and then incubated with 10 µM S1P for the indicated time intervals. The levels of phospho-PKCδ were determined by
Western blot. Data are expressed as mean ± SEM of three independent experiments. #P < 0.01, as compared with the cells exposed to S1P alone.
the PYK2 total protein about 50%, and then significantly
attenuated S1P-induced ICAM-1 expression from 2.1-fold
to 1.1-fold (Figure 4C). Moreover, blocking the activity
of PYK2 with PF431396 also reduced monocyte adhesion
to HPAEpiCs challenged with S1P by approximate 65%
(Figure 4D). Finally, we found that 10 µM S1P time-dependently
stimulated the phosphorylation of PYK2 which was attenuated
by PF431396, GPA2A, GPA2, and Rottlerin (Figure 4E).
Taken together, we suggested that S1P-activated PKCδ and
PYK2 phosphorylation results in ICAM-1 expression in
HPAEpiCs.
NADPH Oxidase-Dependent ROS
Generation is Participated in
S1P-Induced ICAM-1 Expression
Excessive production of ROS by NADPH oxidase from tissue
injury is associated with a range of respiratory inflammatory
diseases (Lee and Yang, 2012). Our previous studies also indicated
that ICAM-1 induction by TNF-α-treatment is mediated
by the NADPH oxidase activation and ROS overproduction
(Lee and Yang, 2012). Moreover, our data indicated that
all of the inhibitors of NADPH oxidase (DPI and APO)
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FIGURE 4 | PYK2 plays a key role in regulating S1P-induced ICAM-1 expression. (A) Cells were pretreated with PF431396 for 1 h, and then incubated with
10 µM S1P for 16 h. The ICAM-1 protein expression was determined by Western blot. (B) Cells were pretreated with PF431396 (1 µM) for 1 h, and then incubated
with 10 µM S1P for 4 h. The ICAM-1 mRNA expression and promoter activity were determined by real-time PCR and promoter assay, respectively. (C) Cells were
transfected with siRNA of scrambled or PYK2, and then incubated with 10 µM S1P for 16 h. The levels of PYK2 and ICAM-1 proteins were determined by Western
blot. (D) Cells were pretreated with PF431396 (1 µM) for 1 h, and then incubated with 10 µM S1P for 16 h. The THP-1 cells adherence was measured. (E) Cells
were pretreated without or with PF431396, Rottlerin, GPA2A, or GPA2 for 1 h, and then incubated with 10 µM S1P for the indicated time intervals. The levels of
phospho-PYK2 were determined by Western blot. Data are expressed as mean ± SEM of three independent experiments. #P < 0.01, as compared with the cells
exposed to S1P alone.
and ROS (Edaravone) markedly reduced S1P-induced ICAM-
1 protein (∼70, 57, and 60%) and mRNA levels (∼74, 67,
and 66%), as well as promoter activity (∼55, 50, and 41%)
(Figures 5A,B). In addition, these three inhibitors also reduced
monocyte adhesion to HPAEpiCs challenged with 10 µM S1P
(Figure 5C). Activated NADPH oxidase is dependent on a
multimeric protein complex formation, in which consists with
at least three cytosolic subunits (p47phox, p67phox, and p40phox)
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FIGURE 5 | NADPH oxidase/ROS play key roles in mediating S1P-induced ICAM-1 expression. (A) Cells were pretreated with APO, DPI, or Edaravone for
1 h, and then incubated with 10 µM S1P for 16 h. The ICAM-1 protein expression was determined by Western blot. (B) Cells were pretreated with APO (10 µM), DPI
(1 µM), or Edaravone (10 µM) for 1 h, and then incubated with 10 µM S1P for 4 h. The ICAM-1 mRNA expression and promoter activity were determined by
real-time PCR and promoter assay, respectively. (C) Cells were pretreated with APO (10 µM), DPI (1 µM), or Edaravone (10 µM) for 1 h, and then incubated with
10 µM S1P for 16 h. The THP-1 cells adherence was measured. (D) Cells were transfected with siRNA of scrambled or p47phox , and then incubated with 10 µM
S1P for 16 h. The levels of p47phox and ICAM-1 proteins were determined by Western blot. (E) Cells were treated with 10 µM S1P for the indicated times. The ROS
production and NADPH oxidase activity were measured. (F) Cells were pretreated with DPI, APO, Rottlerin, or PF431396 for 1 h, and then incubated with 10 µM
S1P for 60 min or 10 min. The ROS production and NADPH oxidase activity were measured. Data are expressed as mean ± SEM of three independent
experiments. #P < 0.01, as compared with the cells exposed to S1P alone (A–C,F) or vehicle alone (E).
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interaction. Because conformational change of phosphorylated
p47phox associated with p22phox, p47phox plays a role as
an “organizer subunit” to organize other cytosolic factor
translocations (Lee and Yang, 2012). We further examined
the role of p47phox in S1P-induced ICAM-1 expression. As
shown in Figure 5D, p47phox siRNA transfection knocked
down the total p47phox protein by approximate 60%, and then
inhibited S1P-enhanced ICAM-1 expression by approximate
41%. Moreover, S1P time-dependently induced both of the
NADPH oxidase activity and intracellular ROS generation
(Figure 5E). Consistently, activation of NADPH oxidase activity
and ROS generation were inhibited by DPI, APO, Rottlerin, or
PF431396 (Figure 5F). Taken together, we suggested that S1P
induces NADPH oxidase/ROS-dependent ICAM-1 expression in
HPAEpiCs.
NF-κB Plays a Key Role in S1P-Induced
ICAM-1 Expression and Monocyte
Adhesion
Activation of the NF-κB is dependent on the phosphorylation
and degradation of IκB (Baeuerle and Baltimore, 1996; Shih
et al., 2015). Upon degradation of IκB, the NF-κB complex
translocates into the nucleus to turn on the transcription
of specific genes that have the κB sites in their promoter
regions. To examine whether NF-κB participates in S1P-
imediated ICAM-1 expression, Bay11-7082 (an inhibitor
of NF-κB) was used to study VCAM-1 expression in
HPAEpiCs. We found that pretreatment with Bay11-7082
significantly reduced S1P-induced ICAM-1 protein in a
dose-dependent manner, by approximate 71% (Figure 6A).
We also obtained the consistent results at transcriptional
analysis that pretreatment of Bay11-7082 attenuates both of
the S1P-induced VCAM-1 mRNA expression approximate 71%
and promoter activity about 77%, respectively (Figure 6B).
Importantly, Bay11-7082 also attenuated monocyte adhesion
to S1P-challenged HPAEpiCs (Figure 6C). To further
confirm that NF-κB is a targeted transcription factor in
S1P-induced ICAM-1 expression in HPAEpiCs, transfection
of p65 siRNA was used to clarify the role of NF-κB in the
S1P-mediated response. The results of Western blotting
indicated that transfection with p65 siRNA significantly
reduced p65 protein expression by approximate 51%, and
then blocked S1P-induced ICAM-1 expression from 3.0-
fold to 1.6-fold in HPAEpiCs (Figure 6D). Moreover, in
our study, we showed that S1P markedly induced NF-κB
65 nuclear translocation, which was inhibited by GPA2A,
Rottlerin, PF431396, DPI, APO, Edaravone, or Bay11-
7082 (Figure 6E). On the other hand, we also found that
10 µM S1P stimulated NF-κB p65 phosphorylation in
a time-dependent manner (Figure 6F, within 30 min).
This induction was also reduced by pretreatment with
Bay11-7082, Rottlerin, PF431396, Edaravone, and DPI
(Figure 6G). Based on these results, we demonstrated that
S1P initiates ROS-dependent NF-κB pathway to induce ICAM-1
expression on HPAEpiCs and resulted in the monocyte
attachment.
S1P Induces ICAM-1 Expression in Lung
Fractions of Mice
To analyze the function of S1P, mice were intratracheally
administered with S1P. The phenotype of lung indicated that
S1P markedly caused pulmonary hematoma (Figure 7A). To
further analyze the effects of pharmacological inhibitors on
S1P-treated mice, mice were i.p. administered with Rottlerin,
PF431396, DPI, Edaravone, Bay11-7082, or GPA2A for 2 h, and
then followed with (3 mg/kg) S1P. The number of leukocytes
(eosinophils and neutrophils) also indicated that after S1P
treatment, leukocyte number is significantly elevated in BAL fluid
and reduced by these inhibitors (Figure 7B). Besides, the total
RNA and protein were extracted from lung tissues to analyze
the levels of ICAM-1 expression. The results of RT/Real-time
PCR indicated that all of the inhibitors Rottlerin, PF431396,
DPI, Edaravone, and Bay11-7082 significantly attenuated S1P-
induced ICAM-1 mRNA by approximate 71% (Figure 7C).
And the results of Western blotting also indicated that
GPA2A, Rottlerin, PF431396, Bay11-7082, DPI, and Edaravone
significantly inhibited S1P-induced ICAM-1 protein expression
by approximate 64% in lung fractions of mice (Figure 7D). These
data demonstrated that S1P-induced lung inflammation is, at
least in part, mediated through an ICAM-1-dependent manner
associated with leukocyte recruitment in the lungs.
DISCUSSION
Asthma, COPD, and several chronic pulmonary diseases are
characterized by various extents of continuous inflammation
and airway remodeling in the respiratory system. The bioactive
sphingolipid metabolite, S1P, activates EDG (endothelial
differentiation gene) receptors and promotes the pro-
inflammatory cytokine expression to enhance allergic responses
in asthma (Ammit et al., 2001). Moreover, stimulation of
S1P promotes expression of cell surface adhesion molecules
to accelerate lung inflammatory injury. Previous reports
indicated that S1P concentration in plasma and tissue exhibits
different levels according to various experimental conditions
(Ammit et al., 2001; Yatomi, 2008; Price et al., 2013). The S1P
concentrations have been shown to be elevated in pulmonary
patients as compared with normal subjects (Ammit et al., 2001;
Knapp et al., 2009, 2013). However, the molecular mechanisms
of S1P induced ICAM-1 expression and infiltration of monocytes
are not fully defined in HPAEpiCs. In contrast to the human,
the S1P concentration is about 0.2–1 µM in the plasma of mice
(Hisano et al., 2012; Kowalski et al., 2013). In this study and our
previous data (Lin et al., 2015), 10 µM S1P was used to obtain
the maximal responses and this induction can be manipulated
with other approached methods such as the inhibitors treatment
and siRNA transfection to dissect out the regulation of signal
transduction pathways. The concentrations of inhibitors used
were about 30-folds of their IC50 values in the literatures
which allowed us to investigate the roles of signaling molecules
involved in S1P-mediated responses in HPAEpiCs. The present
studies demonstrated that S1P-induced ICAM-1 expression
was, at least in part, mediated via Gq- and Gi/o-coupled
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FIGURE 6 | NF-κB plays a key role in mediating S1P-induced ICAM-1 expression. (A) Cells were pretreated with Bay11-7082 for 1 h, and then incubated
with 10 µM S1P for 16 h. The ICAM-1 protein expression was determined by Western blot. (B) Cells were pretreated with Bay11-7082 (100 nM) for 1 h, and then
incubated with 10 µM S1P for 4 h. The ICAM-1 mRNA expression and promoter activity were determined by real-time PCR and promoter assay, respectively.
(C) Cells were pretreated with Bay11-7082 (100 nM) for 1 h, and then incubated with 10 µM S1P for 16 h. The THP-1 cells adherence was measured. (D) Cells
were transfected with siRNA of scrambled or p65, and then incubated with 10 µM S1P for 16 h. The levels of p65 and ICAM-1 proteins were determined by Western
blot. (E) Cells were pretreated with GPA2A, Rottlerin, PF431396, DPI, APO, Edaravone, Bay11-7082 for 1 h or the vehicle control (Basal), and then incubated with
10 µM S1P for 30 min. Cells were fixed and then labeled with an anti-p65 antibody and then FITC-conjugated secondary antibody. Individual cells were enlarged
with 1000x and imaged. The nuclear regions are indicated with solid arrows and the cytoplasmic regions are indicated with dashed arrows. (F) Cells were treated
with 10 µM S1P for the indicated times or (G) pretreated with Bay11-7082, Rottlerin, PF431396, Edaravone, or DPI for 1 h, and then incubated with 10 µM S1P for
the indicated times. The levels of phospho-p65 were determined by Western blot. Data are expressed as mean ± SEM of three independent experiments.
#P < 0.01, as compared with the cells exposed to S1P alone.
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FIGURE 7 | Sphingosine-1-phosphate induces ICAM-1 expression in lung fractions of mice. (A) Mice were intratracheally injected with S1P (3 mg/kg) for
24 h, and then the appearances of the lungs were observed. Mice were intratracheally injected with S1P (3 mg/kg) for 24 h. (B–D) Mice were i.p. given one dose of
DMSO, Rottlerin, PF431396, DPI, Edaravone, Bay11-7082, or GPA2A (2 mg/kg) for 2 h before S1P treatment, and then sacrificed after 24 h. (B) BAL fluid was
acquired and leukocyte count was determined by a hemocytometer. Lung tissues were homogenized to extract proteins and mRNA. The levels of ICAM-1 mRNA
(C) and protein (D) were determined by real-time PCR and Western blot, respectively. Data are expressed as mean ± SEM of three independent experiments
(n = 3). #P < 0.01, as compared with the mice intratracheally injected with S1P alone.
receptors/PKCδ/PYK2/NADPH oxidase/ROS-dependent NF-κB
activation (Figure 8). Genetic silencing through transfection with
siRNA of PKCδ, PYK2, p47phox, or p65 and pretreatment with
the inhibitor of PKCδ (Rottlerin), PYK2 (PF431396), NADPH
oxidase (DPI or APO), ROS (Edaravone), or NF-κB (Bay11-
7082) abrogated S1P-induced ICAM-1 expression and monocyte
adhesion. Therefore, activation of S1P receptors by S1P causes
inflammatory responses through ICAM-1 up-regulation.
Several lines of evidence have reported that diverse biological
effects of S1P are mediated through S1PRs-dependent activity (Li
et al., 2009; Aarthi et al., 2011). Moreover, several reports identify
that S1PR1, S1PR2, and S1PR3 express on various cell types (Ishii
et al., 2004; Brinkmann, 2007; Takashima et al., 2008; Lin et al.,
2015). Indeed, we also found that all of these three receptors
(S1PR1–3) are expressed on HPAEpiCs to mediate S1P-responses
(Lin et al., 2015). S1P receptors belong to the member of G
protein–coupled receptors. The interaction between G protein–
coupled receptors and G protein plays an import role in signal
transmission to mediate cellular responses and behaviors (Shen
et al., 2013, 2015). We found that, in HPAEpiCs, both of the Gq-
and Gi/o-coupled receptors are involved in S1P-induced ICAM-1
expression and monocyte adhesion on HPAEpiCs (Figure 2).
In the PKC family, at least 11 phospholipid-dependent
Ser/Thr kinases, are discovered and engage in a wide array
of pathways to regulate cellular responses and behaviors.
According to the cofactors, PKC isoforms are classified into
three categories dependent on the requirement of optimal
phospholipid-dependent catalytic activity (Lee and Yang, 2013).
S1P has been shown to cause PKCδ activation in A549 human
lung adenocarcinoma cells (Meacci et al., 2003) or human-
airway epithelial cells (Ghelli et al., 2002). Sobel et al. (2013)
indicate that agonists of S1P receptor can activate both of S1P2
and S1P3 receptors to mediate pro-fibrotic responses in human
lung fibroblasts. Previous report also indicates that Gq-linked
PKCδ promotes the downstream cellular reactions (Tu et al.,
2007). Interestingly, we noticed that only Gq-coupled receptors
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FIGURE 8 | Proposed model to illustrate the signaling pathways
involved in ICAM-1 expression and monocyte adhesion in HPAEpiCs
challenged with S1P. S1P-induced ICAM-1 expression and monocyte
adhesion is mediated through Gq-/Gi-coupled receptor/PKCδ/PYK2/NADPH
oxidase/ROS-dependent NF-κB activation.
can be linked to activate S1P-dependent PKCδ activation in
HPAEpiCs but not Gi/o-coupled receptor. This is consistent
to our observations that blocking the activated pathway of
PKCδ effectively reduced S1P-induced ICAM-1 expression and
monocyte adhesion.
Exposure to various stimuli could regulate cell migration,
proliferation, and cell survival which may be mediated through
the focal adhesion tyrosine kinases FAK and PYK2 acted as
critical mediators in these responses (Lee and Yang, 2013). PYK2
is activated by a variety of GPCRs and inflammatory cytokines
that elevate intracellular calcium concentrations (Li et al., 2014).
In HPAEpiCs, we also demonstrated that S1P mediated ICAM-1
expression and monocyte adhesion via PYK2 activation.
Exposure of acinar cells to PMA has been shown to result in
increased phosphorylation of PKCδ and PYK2 (Wrenn, 2001). In
our study, we focused on the inhibition of PKCδ reduced S1P-
mediated PYK2 phosphorylation. Indeed, we found that both
of the inhibitors of Gq-coupled receptor (GPA2A) and Gi/o-
coupled receptor (GPA2) can attenuate the S1P-induced ICAM-1
expression (Figure 2) and PYK2 phosphorylation (Figure 4E).
It is worth noting that pretreatment with rottlerin attenuated
PYK2 phosphorylation stimulated by S1P, indicating that PYK2
is a downstream component of PKCδ. However, to analyze the
phosphorylation of PKCδ (Figure 3E), we noticed that Gq-
coupled receptor mainly plays a key role in this response, but
not Gi/o-coupled receptor. Thus, PKCδ-activated PYK2 plays
important roles in regulating S1P-triggered pulmonary diseases.
Cells and tissues are routinely subjected to sublethal doses
of various oxidants, either exogenously through environmental
exposure or endogenously through inflammatory processes (Lee
and Yang, 2012). ROS are intracellularly generated from several
sources, including mitochondrial respiration, cytochrome P450,
the NADPH oxidase, xanthine oxidase, and arachidonic acid
metabolism (Lee and Yang, 2012). Harijith et al. (2013) indicate
that exogenous S1P stimulates intracellular ROS generation in
human lung microvascular endothelial cells. Golan et al. (2012)
also indicate that S1P can activate S1PR1-mediated ROS signaling
and SDF-1 release to promote murine progenitor cell egress
and mobilization. In NIH3T3 fibroblasts, S1P treatment can
activate the NADPH oxidase and upregulate the generation of
intracellular H2O2 (Catarzi et al., 2011). Moreover, we obtained
the data showing that an important linkage of NADPH oxidase
is established in S1P-induced ROS generation and leading
to ICAM-1 in HPAEpiCs. In the future, other sources, such
as xanthine oxidase or mitochondrial respiration are needed
investigating whether S1P can regulate these ROS generation
processes. PKCδ plays a role in the regulation of NADPH oxidase
1-mediated oxidative stress (Cristovao et al., 2013). PYK2 has also
been shown to regulate ROS generation (Katsume et al., 2011).
In our study, we established that S1P induced NADPH oxidase
activation and ROS production via a PKCδ/PYK2 pathway in
HPAEpiCs. To activate the activity of NADPH oxidase, it requires
the stimulus-induced gp91phox membrane translocation and
association with the Rac (small GTPase), p67phox and p47phox.
In this process, activated p47phox translocates to the membrane
and then recruited p67phox through the association between of
the SH3 domain of p67phox and p47phox C-terminus. Thus, to be
a switch role in ROS generation, p47phox mediates the activation
of NADPH oxidase. In this study, according to the results of
inhibition of p47phox, we proposed that S1P promotes p47phox
translocation leading to activation of NADPH oxidase activity
and ROS generation. The ROS play a role of mediators to regulate
ICAM-1 expression on HPAEpiCs.
The role of NF-κB has been established in inflammatory
responses. Extracellular stimuli are highly dependent on the
various signal transductions to activate NF-κB, which regulates
the transcription of several target genes. Several transcription
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factor response elements are identified on the ICAM-1 promoter
and involved in the transcriptional regulation, including NF-κB
(Roebuck and Finnegan, 1999; Yang C.M. et al., 2010; Hadad
et al., 2011). These studies indicate that to activate NF-κB
is a critical point in ICAM-1 expression within inflammatory
responses. Our results indicated that S1P stimulates both
nuclear translocation and phosphorylation of p65 in HPAEpiCs.
Moreover, we found that blocking the signal transduction
of NF-κB could attenuate S1P-induced ICAM-1 expression.
Consistent with previous reports, our results indicated that NF-
κB is regulated by various signaling components, such as ROS
(Yuan et al., 2014), PKCδ (Lin et al., 2014), or PYK2 (Lee
and Yang, 2013). These consistent results pointed out that in
HPAEpiCs, S1P stimulated NF-κB p65 phosphorylation via a
PKCδ/PYK2/NADPH oxidase/ROS pathway.
CONCLUSION
In summary (Figure 8), our results indicated that challenge with
S1P induces ICAM-1 expression on HPAEpiCs and facilitates
monocyte adhesion. The ICAM-1 induction was mediated
by Gq- and Go/i-coupled receptors/PKCδ/PYK2/NADPH
oxidase/ROS-dependent NF-κB activation. These results provide
new insights into the mechanisms of S1P-induced the expression
of ICAM-1 and monocyte adhesion and thus exaggerate the
inflammatory responses. Increased understanding of signaling
mechanisms underlying ICAM-1 gene expression will promote
the opportunities to develop the anti-inflammation therapeutic
strategies.
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